NO20061626L - Tienopyrazoler - Google Patents

Tienopyrazoler

Info

Publication number
NO20061626L
NO20061626L NO20061626A NO20061626A NO20061626L NO 20061626 L NO20061626 L NO 20061626L NO 20061626 A NO20061626 A NO 20061626A NO 20061626 A NO20061626 A NO 20061626A NO 20061626 L NO20061626 L NO 20061626L
Authority
NO
Norway
Prior art keywords
tienopyrazoler
thienopyrazoles
itk
inhibition
modulated
Prior art date
Application number
NO20061626A
Other languages
English (en)
Norwegian (no)
Inventor
John G Jurcak
Philip Marvin Weintraub
Michael Louis Edwards
Ramalinga M Dharanipragada
Matthicu Barrague
Timothy Alan Gillespy
Kwon Yon Musick
Yan Du
Ashfaq Ahmed Parkar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20061626L publication Critical patent/NO20061626L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20061626A 2003-09-08 2006-04-10 Tienopyrazoler NO20061626L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08
PCT/US2004/023814 WO2005026175A1 (en) 2003-09-08 2004-07-23 Thienopyrazoles

Publications (1)

Publication Number Publication Date
NO20061626L true NO20061626L (no) 2006-04-10

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061626A NO20061626L (no) 2003-09-08 2006-04-10 Tienopyrazoler

Country Status (30)

Country Link
US (2) US7518000B2 (ru)
JP (1) JP4879739B2 (ru)
KR (1) KR20060069490A (ru)
CN (1) CN100398545C (ru)
AT (1) ATE468341T1 (ru)
AU (1) AU2004272507B2 (ru)
BR (1) BRPI0414215A (ru)
CA (1) CA2538032C (ru)
CR (1) CR8255A (ru)
DE (1) DE602004027288D1 (ru)
DK (1) DK1682553T3 (ru)
EC (1) ECSP066411A (ru)
ES (1) ES2345257T3 (ru)
HK (1) HK1095587A1 (ru)
HR (1) HRP20100398T1 (ru)
IL (1) IL173916A (ru)
MA (1) MA28038A1 (ru)
ME (1) MEP20908A (ru)
MX (1) MXPA06001827A (ru)
MY (1) MY144339A (ru)
NO (1) NO20061626L (ru)
NZ (1) NZ545421A (ru)
OA (1) OA13252A (ru)
PT (1) PT1682553E (ru)
RS (2) RS51846B (ru)
RU (1) RU2358978C2 (ru)
TN (1) TNSN06058A1 (ru)
TW (1) TWI352705B (ru)
WO (1) WO2005026175A1 (ru)
ZA (1) ZA200601947B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
US20080293714A1 (en) * 2005-12-20 2008-11-27 Joerg Martin Bentzien Tec Kinase Inhibitors
EP2151434A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
EP2151433A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
UY34893A (es) 2012-07-10 2014-02-28 Takeda Pharmaceutical Derivados de azaindol
WO2014041518A1 (en) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Thienopyrrole derivatives as itk inhibitors
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
KR102452866B1 (ko) 2013-10-25 2022-10-07 파마싸이클릭스 엘엘씨 이식편 대 숙주 질환의 치료 및 예방 방법
UY35945A (es) 2014-01-09 2015-08-31 Takeda Pharmaceutical Derivados de azaindol
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
CN108135904A (zh) 2015-08-31 2018-06-08 药品循环有限责任公司 用于治疗多发性骨髓瘤的btk抑制剂组合
CA3042049A1 (en) 2016-11-03 2018-05-11 Juno Therapeutics, Inc. Combination therapy of a t cell therapy and a btk inhibitor
EP3787751A1 (en) 2018-05-03 2021-03-10 Juno Therapeutics, Inc. Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
WO2023139248A1 (en) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibitors of acyl protein thioesterases against microbial infections
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
ME00370B (me) * 1999-06-23 2011-05-10 Sanofi Aventis Deutschland SUPSTITUISANI BENZIMIDAZOLl
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
WO2003024969A1 (en) * 2001-09-14 2003-03-27 Merck & Co., Inc. Tyrosine kinase inhibitors
JP5039268B2 (ja) * 2001-10-26 2012-10-03 アベンティス・ファーマスーティカルズ・インコーポレイテツド ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr

Also Published As

Publication number Publication date
US7518000B2 (en) 2009-04-14
IL173916A (en) 2011-07-31
HK1095587A1 (en) 2007-05-11
WO2005026175A1 (en) 2005-03-24
RU2358978C2 (ru) 2009-06-20
CN100398545C (zh) 2008-07-02
CR8255A (es) 2006-07-14
PT1682553E (pt) 2010-07-29
NZ545421A (en) 2010-03-26
ATE468341T1 (de) 2010-06-15
ZA200601947B (en) 2007-05-30
MEP20908A (en) 2010-06-10
RS51846B (en) 2012-02-29
MY144339A (en) 2011-08-29
ES2345257T3 (es) 2010-09-20
CA2538032C (en) 2011-01-11
KR20060069490A (ko) 2006-06-21
CA2538032A1 (en) 2005-03-24
TNSN06058A1 (en) 2007-10-03
HRP20100398T1 (hr) 2010-09-30
BRPI0414215A (pt) 2006-11-07
JP2007505038A (ja) 2007-03-08
DE602004027288D1 (en) 2010-07-01
MXPA06001827A (es) 2006-05-31
TW200519118A (en) 2005-06-16
DK1682553T3 (da) 2010-08-23
AU2004272507B2 (en) 2011-05-12
RS20060162A (en) 2008-06-05
TWI352705B (en) 2011-11-21
US7928231B2 (en) 2011-04-19
US20070254937A1 (en) 2007-11-01
IL173916A0 (en) 2006-07-05
OA13252A (en) 2007-01-31
RU2006111470A (ru) 2007-10-27
JP4879739B2 (ja) 2012-02-22
CN1849322A (zh) 2006-10-18
MA28038A1 (fr) 2006-07-03
AU2004272507A1 (en) 2005-03-24
US20100056514A1 (en) 2010-03-04
ECSP066411A (es) 2006-09-18

Similar Documents

Publication Publication Date Title
NO20061626L (no) Tienopyrazoler
ATE318812T1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie
ATE554087T1 (de) Neue kinaseinhibitoren
TW200801008A (en) Protein kinase inhibitors
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
BRPI0512547A (pt) pirimidinas
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
TR200102969T2 (tr) Siklik protein tirozin kinaz önleyicileri.
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
TW200637547A (en) Compounds and compositions as protein kinase inhibitors
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
EA200800546A1 (ru) Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
EA200801430A1 (ru) Производные триазола
WO2007059341A3 (en) Pyrazolothiazole protein kinase modulators
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
WO2007076320A3 (en) Compounds
DK1912954T3 (da) Hidtil ukendte cysteinproteaseinhibitorer og deres terapeutiske applikationer
DE602006003733D1 (de) Pyridopyrazolopyrimidinderivate und ihre anwendung gegen krebs und diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application